3B Medical Files Action Against ResMed

Share Article

3B Medical filed a federal complaint against ResMed (RMD) alleging violations of the Sherman and Clayton Acts, Florida Antitrust Laws, and Tortious Interference.

"This action is intended to restore competition and increase patient choice."

3B Medical, Inc. an innovator and distributor of products used in the treatment of obstructive sleep apnea, has filed a legal action in the United States District Court for the Middle District of Florida (Case No. 8:2015cv00546) alleging antitrust violations by ResMed.

According to court documents, 3B Medical charges ResMed with numerous antitrust violations of the Sherman and Clayton Acts through the use of exclusive contracts, monopolization, unlawful tying, and tortious interference. The initial complaint alleges that ResMed is "choosing winners and losers in the CMS competitive bidding process by preferential pricing," has "created an environment of fear and bullying among customers," and "intentionally interfered in 3B Medical's business relationships."

The court documents assert that the action was brought to "restore competition and increase patient choice in the market for sleep apnea flow generators." Daniel Kotchen of Kotchen & Low LLP, attorneys for 3B Medical stated: "We look forward to an opportunity to present the existence and effect of ResMed’s sales practices to a jury."

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rebecca Velazquez
3B Medical, Inc.
+1 (863) 226-6285 Ext: 108
Email >
Visit website